As previously reported, Craig-Hallum initiated coverage of Nextdoor (KIND) with a Buy rating and $4 price target The firm believes ad platform ...
Craig-Hallum initiated coverage of Nextdoor (KIND) with a Buy rating and $4 price target Invest with Confidence: Follow TipRanks' Top Wall ...
Insider Monkey on MSN8h
Why KIND Is Climbing Today
Nextdoor (KIND) is jumping 7.5% after investment bank Craig-Hallum started coverage of the shares with a Buy rating today.
Fintel reports that on January 28, 2025, Craig-Hallum initiated coverage of Oklo (NYSE:OKLO) with a Buy recommendation.
The emerging, cost-effective Chinese AI alternatives have prompted US President Donald Trump to say it is a wake-up call to ...
Craig-Hallum analyst Chase Knickerbocker raised the firm’s price target on Eton Pharmaceuticals (ETON) to $23 from $18 and keeps a Buy rating on the shares. The firm is updating its model following ...
Fintel reports that on January 21, 2025, Craig-Hallum initiated coverage of Core Scientific, Inc. - Equity Right (OTCPK:CORZR ...
Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) had its target price dropped by stock analysts at Craig Hallum from ...
Agilysys (NASDAQ:AGYS – Get Free Report) had its price target cut by stock analysts at Craig Hallum from $125.00 to $120.00 ...
Craig-Hallum analyst Jeremy Hamblin raised the firm’s price target on Red Robin (RRGB) to $10 from $8.50 and keeps a Buy ...
Management guided Q1 2025 revenue between $204 million and $210 million, signaling a sequential increase. Non-GAAP gross margins are expected to remain flat or slightly improve due to product mix.